ArticleFrontiers in neurology2020

Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study.

Richard J Nowak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.